Joseph Cartwright, MD
Interventional Pain Medicine · St Augustine, FLNPI 1265659460
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $15,968 of the $17,850 with a category attached, or 89.5%. 57 manufacturers reported payments, led by Boston Scientific at 38.9% of the total.
Across 572 payments — averaging $31.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$7K
- AbbVie$2K
- Nevro Corp.$1K
- Relievant Medsystems, Inc.$751
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$694
- Medtronic$488
- plus $6K from 51 others
What the payments were for
- Travel & lodging$1,86510%
- Food & beverage$15,96889%
- Education$170%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$2,064
- WaveWriter Alpha Prime 16$1,281
- Superion Indirect Decompression System$1,147
- WAVEWRITER ALPHA$739
- GENERAL PAIN MANAGEMENT$375
- SPRINT PNS System$283
- Senza$273
- Omnia$261
- Prometra II$185
- SPECTRA WAVEWRITER$139
- PROCLAIM$139
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$128
- Qutenza$126
- RESTORE$125
- UBRELVY$125
- Senza Spinal Cord Stimulation System$115
- AIMOVIG$114
- StimQ Receiver Stimulator Kit Channel A US w Receiver$104
- StimQ Freedom-4A Receiver Kit Channel A US w/ Receiver$104
- StimQ Freedom 8A Receiver Kit Channel A US w Receiver$104
How this compares
$17,850 in reported general payments places this provider in the 80th percentile of 278 interventional pain medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RelistorMethylnaltrexone Bromide | 24 | $57,546 |
| Nucynta ErTapentadol Hcl | 30 | $56,152 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 1,224 | $46,156 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,314 | $33,426 |
| UbrelvyUbrogepant | 21 | $33,406 |
| OxycontinOxycodone Hcl | 38 | $27,623 |
| MovantikNaloxegol Oxalate | 38 | $15,084 |
| QuliptaAtogepant | 13 | $14,976 |
| Gabapentin | 747 | $12,296 |
| Oxycodone Hcl | 565 | $10,444 |
| Fentanyl | 94 | $10,140 |
| Celecoxib | 501 | $7,797 |
| Pregabalin | 412 | $7,668 |
| ButransBuprenorphine | 13 | $6,677 |
| Lidocaine | 56 | $6,549 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Nucynta Er, Xtampza Er | $457 | $62,08541 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $694 | $57,54624 claims |
| AbbVieUbrelvy, Qulipta | $2,054 | $48,38334 claims |
| Redhill Biopharma Inc.Movantik | $13 | $15,08438 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 278 interventional pain medicine providers in Florida.
Other interventional pain medicine in St Augustine
- Kassia SilvaSt Augustine$44K
- Raul MonzonSt Augustine$15K
- Louis RasoJupiter$1.3M
- Ajay AntonyGainesville$1.1M
- Michael EspositoVero Beach$777K
- Nomen AzeemRiverview$650K
- Stanley GolovacMerritt Island$367K
- Sunil PanchalLutz$363K
- Robert BallPort Charlotte$246K
- Justin MannJacksonville$243K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.